Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:24,25-Epoxycholesterol)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteUnits(range)
ST000450 AN000705 Metabolic features of chronic fatigue syndrome Blood Human Myalgic encephalomyelitis/chronic fatigue syndrome University of California, San Diego Area under curve
ST000465 AN000727 Uniquely Tumor-Selective Englerin A Profoundly Alters Lipid Metabolism in Renal Cell Carcinoma inducing ER-Stress and an Acute Inflammatory Response Kidney Human Cancer University of California, San Diego Area under curve
ST000617 AN000947 Validation of the application of targeted metabolomic appraoch in the diagnosis of CFS Blood Human Myalgic encephalomyelitis/chronic fatigue syndrome University of California, San Diego Area under curve
ST000915 AN001486 Biomarkers of NAFLD progression: a lipidomics approach to an epidemic. Part 2:Liver Liver Human Fatty liver disease LIPID MAPS nmol/mg
ST000221 AN000329 Normal plasma cells,Low proliferation multiple myeloma and High proliferation multiple myeloma cells Bone marrow Human Cancer Mayo Clinic Peak area
ST000549 AN000837 Investigating large scale metabolomics in mice serum lacking insulin receptors and IGF-1 receptors Blood Mouse Diabetes Mayo Clinic Peak intensity
ST001289 AN002142 Regulated accumulation of desmosterol integrates macrophage lipid metabolism and inflammatory responses Macrophages Mouse LIPID MAPS pmol/1E6 cells
ST001288 AN002141 Subcellular organelle lipidomics in TLR-4-activated macrophages Macrophages Mouse LIPID MAPS pmol/mg protein
ST000005 AN000012 Timecourse on RAW 264.7 cells treated with Kdo2-Lipid A and compactin Macrophages Mouse LIPID MAPS pmol/ug DNA
ST000916 AN001492 Biomarkers of NAFLD progression: a lipidomics approach to an epidemic. Part 2:Plasma Blood Human Fatty liver disease LIPID MAPS uM
  logo